Pressroom

Informing physicians when a patient dies of an overdose may provide the needed “nudge” to improve prescribing practices.

New analysis of New York data finds considerable variability in patient product choice, even for patients with the same condition.

Average price growth was high among California for-profit systems (31% over the study period), while non-profit and public systems had lower average price growth (13%) than nonsystem hospitals (15%).

Experts from the private and public sectors convened a panel to improve recruitment for Alzheimer’s clinical trials.

Tools used by insurers and PBMs to contain costs result in fewer patients using NOACs or warfarin

Large dialysis chains charge Medicare Advantage plans 27% more than the traditional, fee-for-service Medicare program.

Using multiple medications with known cardiovascular adverse effects at the same time substantially increases cardiovascular risk.

There is little evidence that older adults prescribed benzodiazepines are at increased risk of developing dementia.

A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.

Analysis of cases that went through dispute resolution found the final allowed were largely anchored to the established.